All In Biotech

Free tool

FAERS Monitor: Leuprolide Acetate For Depot Suspension

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205054 or its brand name (Leuprolide Acetate For Depot Suspension, Leuprolide Acetate). Reports on generic versions are filed under their own applications.

Reports

7,124

Serious

6,163

87% of reports

Hospitalization

2,999

Death reported

1,141

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue407
  • drug ineffective377
  • off label use326
  • hot flush312
  • fall283
  • asthenia279
  • death274
  • pneumonia248
  • prostate cancer237
  • nausea236
  • anaemia224
  • diarrhoea207
  • diabetes mellitus194
  • prostatic specific antigen increased194
  • headache187

Reports by year received

View as table
YearReports
200483
200596
200685
2007119
2008351
2009153
2010237
2011236
2012308
201374
201472
2015207
2016125
2017135
2018158
2019165
2020205
2021455
2022773
2023781
2024734
2025838
2026734

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,035 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
prostatic specific antigen increasedSignal19442.236.77,649
hot flushSignal31212.311.03,216
prostate cancerSignal2378.77.71,614
diabetes mellitusSignal1947.56.61,093
anaemiaSignal2243.53.1395
fallSignal2832.52.2260
pneumoniaSignal2482.32.0176
astheniaSignal2792.22.0183
fatigue4071.51.480
off label use3261.11.03
diarrhoea2070.90.81
death2740.90.81
headache1870.90.83
nausea2360.90.84
drug ineffective3770.80.811

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.